Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors
在 NRAS 突变肿瘤患者中,比美替尼治疗 NRAS 12/13 密码子和 61 密码子突变癌症的疗效存在差异(NCI-MATCH II 期试验)
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-0066
Cleary, James M; Wang, Victoria; Heist, Rebecca S; Kopetz, E Scott; Mitchell, Edith P; Zwiebel, James A; Kapner, Kevin S; Chen, Helen X; Li, Shuli; Gray, Robert J; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Meric-Bernstam, Funda; Dillmon, Melissa S; Williams, P Mickey; Hamilton, Stanley R; Conley, Barbara A; Aguirre, Andrew J; O'Dwyer, Peter J; Harris, Lyndsay N; Arteaga, Carlos L; Chen, Alice P; Flaherty, Keith T